Back to company

Selma Diagnostics ApS: Financial statements 2022

CVR: 36961376

Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,636,197 and a net result of DKK -2,768,328 compared with DKK -1,953,914 the year before. Equity amounted to DKK -3,988,932. The company had 2 employees in the financial year.

Gross Profit
-1,636,197 kr.
Profit/Loss
-2,768,328 kr.
Equity
-3,988,932 kr.
Total Assets
516,034 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--1.6 mio.-2.8 mio.-4 mio.2
2021--1.8 mio.-2 mio.-1.2 mio.2
2020--1.6 mio.-2.4 mio.733 t.3
2019--1.9 mio.-2.7 mio.415 t.3
2018--1.7 mio.-2.6 mio.1.5 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Selma Diagnostics ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Selma Diagnostics ApS: The 2021 annual report is outJul 4, 2022

Selma Diagnostics ApS has published its annual report for 2021. Gross profit came to DKK -1,844,276, and the net result was DKK -1,953,914.

About Selma Diagnostics ApS

Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity amounted to DKK -11,154,823.